1. 18F-florbetapir Positron Emission Tomography–determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery. (April 2018) Authors: Klinger, Rebecca Y.; James, Olga G.; Borges-Neto, Salvador; Bisanar, Tiffany; Li, Yi-Ju; Qi, Wenjing; Berger, Miles; Terrando, Niccolò; Newman, Mark F.; Doraiswamy, P. Murali; Mathew, Joseph P.; Weiner, Michael W.; Aisen, Paul; Weiner, Michael; Aisen, Paul; Petersen, Ronald; Jack, Clifford R.; Ja... Journal: Anesthesiology Issue: Volume 128:Number 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [P4–197]: EMERGING AMYLOID PATHOLOGY. (1st July 2017) Authors: Insel, Philip; Ossenkoppele, Rik; Gessert, Devon; Jagust, William J.; Landau, Susan M.; Hansson, Oskar; Weiner, Michael; Mattsson, Niklas Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 28 Page Start: P1340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DT‐02‐03: OPEN LABEL EXTENSION RESULTS FROM A PHASE II/III TRIAL OF INTRANASAL INSULIN. (1st July 2019) Authors: Craft, Suzanne; Raman, Rema; Chow, Tiffany W.; Rafii, Michael S.; Rissman, Robert A.; Brewer, James B.; Donohue, Michael C.; Sun, Chung-Kai; Harless, Kelly; Gessert, Devon; Aisen, Paul S. Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7(2019)Part 28 Page Start: P1489 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Feasibility study for detection of retinal amyloid in clinical trials: The Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial. Issue 1 (17th August 2021) Authors: Ngolab, Jennifer; Donohue, Michael; Belsha, Alison; Salazar, Jennifer; Cohen, Paula; Jaiswal, Sandhya; Tan, Veasna; Gessert, Devon; Korouri, Shaina; Aggarwal, Neelum T.; Alber, Jessica; Johnson, Ken; Jicha, Gregory; van Dyck, Christopher; Lah, James; Salloway, Stephen; Sperling, Reisa A.; Aisen, ... Journal: Alzheimer's & dementia Issue: Volume 13:Issue 1(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P1‐338: Assessing Risk for Preclinical β‐Amyloid Pathology with APOE, Cognitive and Demographic Information. (1st July 2016) Authors: Insel, Philip S.; Palmqvist, Sebastian; Mackin, Scott; Nosheny, Rachel L.; Gessert, Devon; Hansson, Oskar; Weiner, Michael W.; Mattsson, Niklas Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 11 Page Start: P558 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Type 2 diabetes mellitus, brain atrophy, and cognitive decline. (19th February 2019) Authors: Moran, Chris; Beare, Richard; Wang, Wei; Callisaya, Michele; Srikanth, Velandai; Weiner, Michael; Aisen, Paul; Weiner, Michael; Aisen, Paul; Petersen, Ronald; Jack, Clifford R.; Jagust, William; Trojanowki, John Q.; Toga, Arthur W.; Beckett, Laurel; Green, Robert C.; Saykin, Andrew J.; Morris, Jo... Journal: Neurology Issue: Volume 92:Number 8(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Utilizing study and site performance metrics to improve efficiency of clinical trials: An initiative of the Alzheimer's Clinical Trials Consortium (ACTC). (31st December 2021) Authors: Walter, Sarah; Craft, Suzanne; Geldmacher, David S.; Menard, William; Sano, Mary; Obisesan, Thomas O; Combs, Martha; Gessert, Devon; Shaffer‐Bacareza, Elizabeth; Miller, Garrett; Donohue, Michael C; Rafii, Michael S; Aisen, Paul S Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗